Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-003370
Filing Date
2014-01-22
Accepted
2014-01-22 18:19:25
Documents
2
Period of Report
2014-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd400384.html 4  
1 FORM 4 rrd400384.xml 4 3805
2 POWER OF ATTORNEY rrd360303_408230.htm EX-24.1 4069
  Complete submission text file 0001181431-14-003370.txt   9258
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Yarranton Geoffrey Thomas (Reporting) CIK: 0001555737 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 14541178